Healthcare Valuation and Due Diligence

Handle executes Healthcare Valuation and Due Diligence as a single, institutional mandate — integrating financial analytics, clinical performance assessment, regulatory review, and operational benchmarking across healthcare providers, platforms, and assets in the UAE and wider region.

We structure healthcare transactions for enforceability and downside protection; quantifying risk in revenue, licenses, payer contracts, physicians, and infrastructure, then converting that risk into covenants, pricing, and governance terms. The outcome is clear: capital deployed with evidence, healthcare exposure ring-fenced, and post-close integration controlled.

Healthcare assets do not behave like generic operating companies. Clinical risk, regulation, payer dynamics, and reputation sit directly on valuation, covenants, and exit options.

Handle structures healthcare diligence and valuation around enforcement, not narratives — aligning acquisition economics, shareholder arrangements, and financing structures with what regulators, payors, and clinicians will actually permit and sustain.

• Dedicated healthcare transaction experience across UAE and GCC jurisdictions
• Integrated view of clinical, financial, regulatory, and operational risk
• Direct linkage between diligence findings and SPA, SHA, and financing terms
• Fluency with MOH, DOH, DHA, and free zone healthcare regulatory frameworks
• Execution model aligned to private capital, family enterprise, and institutional mandates
• Outcome-owned deliverables: valuation cases, risk pricing, and enforceable protections

We execute a full-stack diligence and valuation program tailored to healthcare assets, integrating clinical, operational, financial, and regulatory dimensions into a single, decision-ready output.

Every finding is wired into valuation scenarios, covenant design, and downside protections, ensuring capital is deployed with clarity on risk, remediation options, and enforcement routes.

• Valuation models incorporating payer agreements, tariff changes, and capacity utilization
• Revenue cycle and billing integrity reviews, including coding, denials, and collections
• Clinical operations review: pathways, staffing, quality KPIs, and accreditation dependencies
• Regulatory and licensing verification across MOH, DOH, DHA, and free zones
• Contractual diligence on insurers, group purchasing, suppliers, and physician arrangements
• Compliance and risk mapping: data protection, clinical negligence, and ESG-sensitive exposures
• Scenario analysis for growth, consolidation, buy-and-build, and exit options
• Transaction impact memo: pricing, SPA/SHA protections, integration priorities, and monitoring metrics